AirSculpt [AIRS] vs HCA Healthcare [HCA] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: AirSculpt Technologies Inc. wins in 7 metrics, HCA Healthcare Inc. wins in 12 metrics, with 0 ties. HCA Healthcare Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | AirSculpt Technologies Inc. | HCA Healthcare Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 197.00 | 16.86 | HCA Healthcare Inc. |
| Price-to-Book Ratio | 1.79 | -38.44 | AirSculpt Technologies Inc. |
| Debt-to-Equity Ratio | 95.28 | -17.57 | AirSculpt Technologies Inc. |
| PEG Ratio | -1.61 | 0.37 | HCA Healthcare Inc. |
| EV/EBITDA | 31.11 | 10.08 | HCA Healthcare Inc. |
| Profit Margin (TTM) | -7.69% | 8.97% | HCA Healthcare Inc. |
| Operating Margin (TTM) | -4.56% | 16.29% | HCA Healthcare Inc. |
| EBITDA Margin (TTM) | N/A | 16.29% | N/A |
| Return on Equity | -14.06% | -244.82% | AirSculpt Technologies Inc. |
| Return on Assets (TTM) | -1.51% | 12.44% | HCA Healthcare Inc. |
| Free Cash Flow (TTM) | $692,000 | $7.69B | HCA Healthcare Inc. |
| Dividend Yield | N/A | 0.59% | N/A |
| 1-Year Return | 17.58% | 4.31% | AirSculpt Technologies Inc. |
| Price-to-Sales Ratio (TTM) | 1.13 | 1.39 | AirSculpt Technologies Inc. |
| Enterprise Value | $247.25M | $156.18B | HCA Healthcare Inc. |
| EV/Revenue Ratio | 1.63 | 2.07 | AirSculpt Technologies Inc. |
| Gross Profit Margin (TTM) | 59.11% | 41.90% | AirSculpt Technologies Inc. |
| Revenue per Share (TTM) | $3 | $320 | HCA Healthcare Inc. |
| Earnings per Share (Diluted) | $-0.19 | $27.94 | HCA Healthcare Inc. |
| Beta (Stock Volatility) | 2.27 | 1.37 | HCA Healthcare Inc. |
| Short % of Float | 12.84% | 2.45% | HCA Healthcare Inc. |
AirSculpt Technologies Inc. vs HCA Healthcare Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| AirSculpt Technologies Inc. | -5.05% | 0.99% | 5.83% | 80.78% | 93.16% | 174.59% |
| HCA Healthcare Inc. | 0.72% | 7.93% | -7.81% | -25.75% | -18.24% | -17.10% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| AirSculpt Technologies Inc. | 17.58% | -31.93% | -66.33% | -66.33% | -66.33% | -66.33% |
| HCA Healthcare Inc. | 4.31% | 33.47% | 92.28% | 400.04% | 1,019.34% | 1,144.15% |
Performance & Financial Health Analysis: AirSculpt Technologies Inc. vs HCA Healthcare Inc.
| Metric | AIRS | HCA |
|---|---|---|
| Market Information | ||
| Market Cap | $172.13M | $106.00B |
| Market Cap Category | Micro cap | Large cap |
| 10 Day Avg. Volume | 1,167,235 | 795,641 |
| 90 Day Avg. Volume | 4,496,622 | 974,074 |
| Last Close | $5.08 | $389.97 |
| 52 Week Range | $1.51 - $12.00 | $330.00 - $556.52 |
| % from 52W High | -57.67% | -29.93% |
| All-Time High | $18.48 (Dec 27, 2021) | $556.52 (Mar 12, 2026) |
| % from All-Time High | -72.51% | -29.93% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.15% | 0.07% |
| Quarterly Earnings Growth | N/A | 0.31% |
| Financial Health | ||
| Profit Margin (TTM) | -0.08% | 0.09% |
| Operating Margin (TTM) | -0.05% | 0.16% |
| Return on Equity (TTM) | -0.14% | -2.45% |
| Debt to Equity (MRQ) | 95.28 | -17.57 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.36 | $-26.83 |
| Cash per Share (MRQ) | $0.12 | $5.11 |
| Operating Cash Flow (TTM) | $3.10M | $12.64B |
| Levered Free Cash Flow (TTM) | $5.17M | $5.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.59% |
| Last 12-Month Dividend | $0.00 | $2.94 |
Valuation & Enterprise Metrics Analysis: AirSculpt Technologies Inc. vs HCA Healthcare Inc.
| Metric | AIRS (Apr 26, 2026) | HCA (Apr 23, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 197.00 | 16.86 |
| Forward P/E | -81.33 | 14.13 |
| PEG Ratio | -1.61 | 0.37 |
| Price to Sales (TTM) | 1.13 | 1.39 |
| Price to Book (MRQ) | 1.79 | -38.44 |
| Market Capitalization | ||
| Market Capitalization | $172.13M | $106.00B |
| Enterprise Value | $247.25M | $156.18B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.63 | 2.07 |
| Enterprise to EBITDA | 31.11 | 10.08 |
| Risk & Other Metrics | ||
| Beta | 2.27 | 1.37 |
| Book Value per Share (MRQ) | $1.36 | $-26.83 |
Financial Statements Comparison: AirSculpt Technologies Inc. vs HCA Healthcare Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | AIRS (2025) | HCA (2025) |
|---|---|---|
| Revenue/Sales | 151.82M | 75.60B |
| Cost of Goods Sold | 61.69M | 44.23B |
| COGS % of Revenue | 40.6% | 58.5% |
| Gross Profit | 90.13M | 31.37B |
| Gross Margin | 59.4% | 41.5% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -4.83M | 11.97B |
| Operating Margin | -3.2% | 15.8% |
| EBITDA | 7.95M | 15.57B |
| EBITDA Margin | 5.2% | 20.6% |
| Pre-Tax Income | -17.64M | 9.83B |
| Pre-Tax Income % of Revenue | -11.6% | 13.0% |
| Income Tax | -5.97M | 2.05B |
| Income Tax % of Revenue | -3.9% | 2.7% |
| Net Income (Profit) | -11.67M | 7.78B |
| Profit Margin | -7.7% | 10.3% |
Balance Sheet & Liquidity Metrics
| Metric | AIRS (2025) | HCA (2025) |
|---|---|---|
| Cash & Equivalents | 8.45M | 1.04B |
| Total Current Assets | 15.46M | 15.78B |
| Total Current Assets % of Revenue | 10.2% | 20.9% |
| Total Current Liabilities | 27.90M | 16.35B |
| Total Current Liabilities % of Revenue | 18.4% | 21.6% |
| Long-Term Debt | 70.81M | 43.46B |
| Long-Term Debt % of Revenue | 46.6% | 57.5% |
| Total Shareholders Equity | 87.71M | -2.77B |
| Retained Earnings | -40.57M | -5.72B |
| Retained Earnings % of Revenue | -26.7% | -7.6% |
| Property, Plant & Equipment | 35.53M | 39.12B |
Cash Flow Statement Comparison
| Metric | AIRS (2025) | HCA (2025) |
|---|---|---|
| Operating Cash Flow | 9.75M | 12.01B |
| Operating Cash Flow % of Revenue | 6.4% | 15.9% |
| Capital Expenditures | -2.40M | -4.94B |
| Free Cash Flow | 692,000 | 7.69B |
| FCF Margin | 0.5% | 10.2% |
| Debt Repayment | -18.79M | -7.39B |
| Common Stock Repurchase | N/A | -10.07B |
Short Interest & Institutional Ownership Analysis
| Metric | AIRS | HCA |
|---|---|---|
| Shares Short | 5.07M | 3.63M |
| Short Ratio | 0.94 | 3.37 |
| Short % of Float | 12.84% | 2.45% |
| Shares Outstanding | 64.54M | 224.61M |
| Float Shares | 9.96M | 151.19M |
| % Held by Insiders | 42.64% | 16.16% |
| % Held by Institutions | 67.65% | 78.70% |
| % Held by Public | -10.29% | 5.14% |
Dividend Analysis & Yield Comparison: AirSculpt Technologies Inc. vs HCA Healthcare Inc.
| Metric | AIRS | HCA |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $2.94 |
| Last 12-Month Dividend Yield | N/A | 0.59% |
| 3-Year Avg Annual Dividend | $0.14 | $2.70 |
| 3-Year Avg Dividend Yield | 4.58% | 0.19% |
| 3-Year Total Dividends | $0.41 | $8.10 |
| Ex-Dividend Date | Aug 25, 2022 | Mar 17, 2026 |